Abstract
SJG-136 (NSC 694501) is a novel DNA cross-linking agent that binds in a sequence-selective manner in the minor groove of the DNA helix. It is structurally novel compared with other clinically used DNA cross-linking agents and has exhibited a unique multilog differential pattern of activity in the NCI 60-cell line screen (i.e., is COMPARE negative to other cross-linking agents). Given this profile, we undertook a preclinical evaluation of SJG-136 in primary tumor cells derived from 34 B-cell chronic lymphocytic leukemia (B-CLL) patients. SJG-136 induced apoptosis in all of the B-CLL samples tested with a mean LD50 value (the concentration of drug required to kill 50% of the cells) of 9.06 nmol/L. Its cytotoxicity was undiminished in B-CLL cells derived from patients treated previously, those with unmutated VH genes, and those with p53 mutations (P=0.17; P=0.63; P=0.42, respectively). SJG-136-induced apoptosis was associated with the activation of caspase-3 that could be partially abrogated by the caspase-9 inhibitor Z-LEHD-FMK. Furthermore, SJG-136 did not trigger the phosphorylation of p53 or the up-regulation of GADD45 expression in B-CLL cells whereas the cross-linking agent chlorambucil elicited both of these effects. This s...Continue Reading
References
Jul 1, 1981·Cancer·J L BinetF Gremy
Jul 17, 1995·Journal of Immunological Methods·I VermesC Reutelingsperger
Dec 23, 1994·Journal of Medicinal Chemistry·T C JenkinsD E Thurston
Sep 16, 1994·Journal of Medicinal Chemistry·J A MountzourisL H Hurley
Jun 1, 1996·Cytometry·C FerliniA Fattorossi
Mar 23, 1999·British Journal of Haematology·C PepperP Bentley
Mar 23, 2001·Journal of Medicinal Chemistry·S J GregsonD E Thurston
Nov 9, 2001·Leukemia & Lymphoma·C PepperP Bentley
Nov 26, 2002·Blood·Chris PepperChris Fegan
Jul 9, 2003·Biochemistry·Melissa SmellieDavid E Thurston
Sep 27, 2003·British Journal of Haematology·Jane StarczynskiChristopher Fegan
Feb 20, 2004·Journal of Medicinal Chemistry·Stephen J GregsonDavid E Thurston
Sep 18, 2004·Cancer Research·John A HartleyDavid E Thurston
Sep 18, 2004·Cancer Research·Michael C AlleyEdward A Sausville
Citations
Dec 29, 2010·Cancer Chemotherapy and Pharmacology·Joel M ReidMatthew M Ames
Mar 22, 2013·Journal of Medicinal Chemistry·Khondaker M RahmanDavid E Thurston
Apr 2, 2005·Nature Reviews. Cancer·Stephen Neidle, David E Thurston
Apr 22, 2006·Leukemia·A J SteeleR G Wickremasinghe
Jun 15, 2007·The Pharmacogenomics Journal·R E AirdS M Guichard
May 2, 2012·The Journal of Antimicrobial Chemotherapy·Khondaker M RahmanPeter W Taylor
Jul 28, 2010·Cancer Research·John A HartleyPhilip W Howard
Apr 5, 2011·Expert Opinion on Investigational Drugs·John A Hartley
Jun 15, 2010·Medicinal Research Reviews·Barbara Gerratana
Jul 28, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S M GuichardD I Jodrell
Nov 27, 2010·Molecular Cancer·Giovanni L GravinaVincenzo Tombolini
May 12, 2016·The Journal of Antibiotics·Federico BrucoliSanjib Bhakta
Sep 30, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yong MaDonglu Zhang
Jun 21, 2007·British Journal of Cancer·C PepperP Delavault
Mar 21, 2018·Targeted Oncology·Cédric RossiRené-Olivier Casasnovas
Aug 16, 2008·Molecular BioSystems·Paul BrennanSaman Hewamana
Nov 26, 2008·ChemMedChem·Lech-Gustav MilroySteven V Ley
Jun 19, 2007·Molecular Cancer Therapeutics·Tanyel KiziltepeKenneth C Anderson
Apr 3, 2007·Journal of Combinatorial Chemistry·Dyeison AntonowDavid E Thurston
Mar 16, 2005·Biochemistry·Chris MartinDavid E Thurston